Balance Sheet
Cash Flow Statement
Cash from Financing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesChange in TaxesDepreciation & Amortization (CF)Free Cash FlowLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesShort-Term Debt issuances
Growth Metrics
Income Statement
Others
Ratios

Bio Essence (BIOE) Cash from Operations (2020 - 2025)

Bio Essence (BIOE) has 6 years of Cash from Operations data on record, last reported at 186973.0 in Q3 2025.

  • For Q3 2025, Cash from Operations fell 62.14% year-over-year to 186973.0; the TTM value through Sep 2025 reached 614990.0, up 246.09%, while the annual FY2024 figure was 623865.0, 163.57% up from the prior year.
  • Cash from Operations reached 186973.0 in Q3 2025 per BIOE's latest filing, up from 167797.0 in the prior quarter.
  • Across five years, Cash from Operations topped out at 493916.0 in Q3 2024 and bottomed at 819791.0 in Q2 2021.
  • Average Cash from Operations over 5 years is 95768.74, with a median of 142565.0 recorded in 2021.
  • Peak YoY movement for Cash from Operations: crashed 434.89% in 2023, then skyrocketed 998.65% in 2025.
  • A 5-year view of Cash from Operations shows it stood at 142565.0 in 2021, then skyrocketed by 154.27% to 77363.0 in 2022, then plummeted by 306.66% to 159880.0 in 2023, then soared by 279.06% to 286289.0 in 2024, then plummeted by 34.69% to 186973.0 in 2025.
  • Per Business Quant database, its latest 3 readings for Cash from Operations were 186973.0 in Q3 2025, 167797.0 in Q2 2025, and 26069.0 in Q1 2025.